 Felix Poppelaars
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complement System Proteins | 11 | 2023 | 285 | 3.000 |
Why?
| | Complement Activation | 15 | 2023 | 340 | 2.420 |
Why?
| | Kidney Diseases | 7 | 2023 | 350 | 2.040 |
Why?
| | Peritoneal Dialysis | 3 | 2023 | 83 | 1.620 |
Why?
| | Renal Dialysis | 5 | 2019 | 369 | 1.530 |
Why?
| | Interleukin-6 | 4 | 2022 | 675 | 1.450 |
Why?
| | Kidney Failure, Chronic | 6 | 2020 | 487 | 1.350 |
Why?
| | Brain Death | 3 | 2019 | 31 | 1.310 |
Why?
| | Kidney Transplantation | 5 | 2021 | 541 | 1.100 |
Why?
| | Inflammation | 3 | 2021 | 2481 | 0.930 |
Why?
| | Macular Degeneration | 2 | 2022 | 152 | 0.830 |
Why?
| | Receptors, Interleukin-6 | 1 | 2021 | 34 | 0.770 |
Why?
| | Interleukin-10 | 1 | 2022 | 296 | 0.730 |
Why?
| | Receptors, Complement | 1 | 2021 | 111 | 0.720 |
Why?
| | Tissue Donors | 3 | 2021 | 317 | 0.670 |
Why?
| | Graft Rejection | 2 | 2021 | 516 | 0.630 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 486 | 0.610 |
Why?
| | Complement C1 Inhibitor Protein | 1 | 2018 | 7 | 0.600 |
Why?
| | Mannose-Binding Lectin | 2 | 2016 | 21 | 0.580 |
Why?
| | Complement C3 | 1 | 2018 | 189 | 0.580 |
Why?
| | Complement Factor H | 3 | 2022 | 60 | 0.570 |
Why?
| | Receptor, Anaphylatoxin C5a | 1 | 2017 | 28 | 0.560 |
Why?
| | Kidney | 8 | 2023 | 1184 | 0.560 |
Why?
| | Dialysis Solutions | 3 | 2023 | 21 | 0.560 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 1727 | 0.530 |
Why?
| | Reperfusion Injury | 1 | 2017 | 254 | 0.480 |
Why?
| | Pandemics | 1 | 2022 | 1319 | 0.470 |
Why?
| | Properdin | 3 | 2023 | 8 | 0.400 |
Why?
| | Glomerulonephritis | 2 | 2023 | 45 | 0.380 |
Why?
| | Research Personnel | 2 | 2022 | 151 | 0.360 |
Why?
| | Complement Factor B | 2 | 2022 | 100 | 0.350 |
Why?
| | Allografts | 2 | 2022 | 122 | 0.320 |
Why?
| | Humans | 25 | 2023 | 114714 | 0.300 |
Why?
| | Complement C1q | 3 | 2023 | 37 | 0.300 |
Why?
| | Animals | 13 | 2023 | 31761 | 0.290 |
Why?
| | Complement Factor D | 2 | 2023 | 27 | 0.260 |
Why?
| | Pancreatic Elastase | 1 | 2023 | 65 | 0.220 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2023 | 57 | 0.220 |
Why?
| | Complement C3d | 3 | 2023 | 60 | 0.220 |
Why?
| | Pemphigoid, Bullous | 1 | 2023 | 7 | 0.210 |
Why?
| | Complement C3b | 1 | 2023 | 30 | 0.210 |
Why?
| | Risk Factors | 3 | 2022 | 8626 | 0.210 |
Why?
| | Complement Inactivating Agents | 2 | 2020 | 41 | 0.210 |
Why?
| | Complement Membrane Attack Complex | 3 | 2019 | 33 | 0.210 |
Why?
| | Maltose | 2 | 2019 | 5 | 0.210 |
Why?
| | Biopsy | 3 | 2021 | 1040 | 0.210 |
Why?
| | Lectins | 2 | 2020 | 43 | 0.200 |
Why?
| | Immunoglobulin M | 1 | 2023 | 250 | 0.200 |
Why?
| | Ferric Compounds | 2 | 2019 | 40 | 0.200 |
Why?
| | CD59 Antigens | 1 | 2020 | 21 | 0.190 |
Why?
| | Rats, Inbred F344 | 2 | 2019 | 241 | 0.180 |
Why?
| | Peritoneum | 1 | 2020 | 36 | 0.180 |
Why?
| | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2020 | 20 | 0.180 |
Why?
| | Atypical Hemolytic Uremic Syndrome | 1 | 2020 | 18 | 0.180 |
Why?
| | Antigen-Antibody Complex | 1 | 2020 | 88 | 0.180 |
Why?
| | Complement C4b | 1 | 2020 | 9 | 0.180 |
Why?
| | Glomerulonephritis, IGA | 1 | 2020 | 7 | 0.180 |
Why?
| | Oligosaccharides | 1 | 2020 | 46 | 0.170 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2020 | 21 | 0.170 |
Why?
| | Kidney Glomerulus | 1 | 2020 | 100 | 0.170 |
Why?
| | Pneumothorax | 1 | 2019 | 40 | 0.170 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 70 | 0.160 |
Why?
| | Endometriosis | 1 | 2019 | 40 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 797 | 0.160 |
Why?
| | Heparin | 1 | 2020 | 222 | 0.160 |
Why?
| | von Willebrand Factor | 1 | 2018 | 56 | 0.160 |
Why?
| | Anemia | 1 | 2019 | 144 | 0.150 |
Why?
| | Hemodiafiltration | 1 | 2018 | 9 | 0.150 |
Why?
| | Male | 10 | 2022 | 55558 | 0.150 |
Why?
| | Antibodies, Monoclonal | 2 | 2023 | 1270 | 0.140 |
Why?
| | Iron Compounds | 1 | 2016 | 5 | 0.140 |
Why?
| | Glomerular Filtration Rate | 1 | 2020 | 604 | 0.140 |
Why?
| | Morbidity | 1 | 2018 | 277 | 0.140 |
Why?
| | Hematinics | 1 | 2016 | 18 | 0.140 |
Why?
| | Neutrophil Activation | 1 | 2017 | 94 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 450 | 0.130 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 53 | 0.130 |
Why?
| | Mortality | 1 | 2018 | 288 | 0.130 |
Why?
| | Risk | 1 | 2018 | 815 | 0.130 |
Why?
| | Leukocytes | 1 | 2017 | 277 | 0.130 |
Why?
| | Female | 10 | 2023 | 59485 | 0.130 |
Why?
| | Thrombosis | 1 | 2018 | 297 | 0.120 |
Why?
| | Cause of Death | 1 | 2016 | 362 | 0.120 |
Why?
| | Prognosis | 2 | 2020 | 3334 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2018 | 635 | 0.110 |
Why?
| | Toll-Like Receptor 2 | 1 | 2014 | 109 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 815 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 1892 | 0.110 |
Why?
| | Biomarkers | 2 | 2020 | 3414 | 0.110 |
Why?
| | Reproducibility of Results | 1 | 2021 | 2762 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1134 | 0.110 |
Why?
| | Follow-Up Studies | 2 | 2020 | 4420 | 0.110 |
Why?
| | Mice | 5 | 2023 | 14916 | 0.110 |
Why?
| | Cell Movement | 1 | 2017 | 867 | 0.100 |
Why?
| | Rats | 2 | 2018 | 4943 | 0.100 |
Why?
| | Middle Aged | 5 | 2019 | 26746 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 286 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3542 | 0.100 |
Why?
| | Neutrophils | 1 | 2017 | 1163 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1795 | 0.100 |
Why?
| | Prospective Studies | 1 | 2022 | 6216 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2019 | 6346 | 0.090 |
Why?
| | Mice, Knockout | 1 | 2017 | 2582 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2017 | 2557 | 0.080 |
Why?
| | Aging | 1 | 2018 | 1620 | 0.080 |
Why?
| | Adult | 5 | 2021 | 30543 | 0.080 |
Why?
| | Cohort Studies | 1 | 2018 | 4899 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2321 | 0.070 |
Why?
| | Administration, Intravenous | 2 | 2019 | 124 | 0.070 |
Why?
| | Aged | 3 | 2019 | 19079 | 0.070 |
Why?
| | Disease Progression | 2 | 2022 | 2384 | 0.060 |
Why?
| | Complement Factor I | 1 | 2022 | 12 | 0.050 |
Why?
| | Doxorubicin | 1 | 2023 | 286 | 0.050 |
Why?
| | Epitopes | 1 | 2023 | 435 | 0.050 |
Why?
| | Fibrinogen | 1 | 2022 | 154 | 0.050 |
Why?
| | Mice, Inbred BALB C | 1 | 2023 | 1151 | 0.050 |
Why?
| | Dexamethasone | 1 | 2023 | 317 | 0.050 |
Why?
| | Antibodies | 1 | 2023 | 371 | 0.050 |
Why?
| | Heparitin Sulfate | 1 | 2020 | 39 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 220 | 0.040 |
Why?
| | Pleurodesis | 1 | 2019 | 7 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2023 | 774 | 0.040 |
Why?
| | Thoracoscopy | 1 | 2019 | 53 | 0.040 |
Why?
| | Peroxidase | 1 | 2019 | 157 | 0.040 |
Why?
| | Swine | 1 | 2020 | 700 | 0.040 |
Why?
| | Sheep | 1 | 2020 | 764 | 0.040 |
Why?
| | Cattle | 1 | 2020 | 921 | 0.040 |
Why?
| | Glucaric Acid | 1 | 2016 | 3 | 0.040 |
Why?
| | Iron-Dextran Complex | 1 | 2016 | 9 | 0.040 |
Why?
| | Disaccharides | 1 | 2016 | 16 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 936 | 0.030 |
Why?
| | Ferrosoferric Oxide | 1 | 2016 | 25 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2020 | 530 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12512 | 0.030 |
Why?
| | Graft Survival | 1 | 2017 | 452 | 0.030 |
Why?
| | Frozen Sections | 1 | 2014 | 24 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1013 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 1896 | 0.030 |
Why?
| | Antibody Specificity | 1 | 2014 | 176 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 2811 | 0.030 |
Why?
| | Demography | 1 | 2014 | 262 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2017 | 664 | 0.030 |
Why?
| | Living Donors | 1 | 2014 | 270 | 0.030 |
Why?
| | Cytokines | 1 | 2019 | 1843 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1635 | 0.020 |
Why?
| | Lung | 1 | 2020 | 3546 | 0.020 |
Why?
| | Signal Transduction | 1 | 2018 | 4521 | 0.020 |
Why?
|
|
Poppelaars's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|